Slaoui; Moncef Mohamed
Patent Applications and Registrations
Patent applications and USPTO patent grants for Slaoui; Moncef Mohamed.The latest application filed is for "novel vaccine".
- Slaoui; Moncef Mohamed - Rixensart BE
- Slaoui; Moncef Mohamed - King of Prussia PA
| Patent | Date |
|---|---|
| Methods for one-dose intradermal delivery for non-live trivalent influenza vaccine Grant 9,138,471 - Garcon , et al. September 22, 2 | 2015-09-22 |
| Novel Vaccine App 20140302090 - GARCON; NATHALIE ; et al. | 2014-10-09 |
| Process for the production of immunogenic compositions Grant 8,597,656 - Silva , et al. December 3, 2 | 2013-12-03 |
| Non-live trivalent influenza vaccine for one-dose intradermal delivery Grant 8,557,251 - Garcon , et al. October 15, 2 | 2013-10-15 |
| Process For The Production Of Immunogenic Compositions App 20120269835 - Cabezon Silva; Teresa ; et al. | 2012-10-25 |
| Methods For One-dose Intradermal Delivery For Non-live Trivalent Influenza Vaccine App 20120039933 - Garcon; Nathalie ; et al. | 2012-02-16 |
| Kits For One-dose Intradermal Delivery For Non-live Trivalent Influenza Vaccine App 20120029437 - Garcon; Nathalie ; et al. | 2012-02-02 |
| MAGE3 polypeptides Grant 8,097,257 - Cabezon Sil Va , et al. January 17, 2 | 2012-01-17 |
| Process for the production of immunogenic compositions Grant 8,044,183 - Cabezon Silva , et al. October 25, 2 | 2011-10-25 |
| MAGE3 Polypeptides App 20100209444 - CABEZON SIL VA; TERESA ; et al. | 2010-08-19 |
| Process for the Production of Immunogenic Compositions App 20100204458 - Silva; Teresa Cabezon ; et al. | 2010-08-12 |
| Chlamydia Vaccines App 20080102112 - MAISONNEUVE; Jean-Francois Lucien ; et al. | 2008-05-01 |
| Non-live Trivalent Influenza Vaccine For One-dose Intradermal Delivery App 20070237788 - GARCON; Nathalie ; et al. | 2007-10-11 |
| Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein App 20070116714 - Slaoui; Moncef Mohamed ; et al. | 2007-05-24 |
| Composition Grant 7,220,551 - Slaoui May 22, 2 | 2007-05-22 |
| Novel composition App 20060280756 - Slaoui; Moncef Mohamed | 2006-12-14 |
| Vaccine and method of use App 20050238659 - Slaoui, Moncef Mohamed ; et al. | 2005-10-27 |
| Chylamydia vaccine App 20050208123 - Maisonneuve, Jean-Francois Lucien ; et al. | 2005-09-22 |
| Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein App 20050129707 - Slaoui, Moncef Mohamed ; et al. | 2005-06-16 |
| Novel method App 20040191834 - Laferriere, Craig Antony Joseph ; et al. | 2004-09-30 |
| Vaccine and method of use App 20040151734 - Slaoui, Moncef Mohamed ; et al. | 2004-08-05 |
| Novel vaccine App 20040096463 - Garcon, Nathalie ; et al. | 2004-05-20 |
| Novel vaccine App 20040071734 - Garcon, Nathalie ; et al. | 2004-04-15 |
| Methods of treating human females susceptible to HSV infection Grant 6,692,752 - Slaoui , et al. February 17, 2 | 2004-02-17 |
| Vaccines App 20030219453 - Maisonneuve, Jean-Francois Lucien ; et al. | 2003-11-27 |
| Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein App 20030157129 - Slaoui, Moncef Mohamed ; et al. | 2003-08-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 